Early Symptomatic Phase Alzheimer's Disease
Early symptomatic phase Alzheimer's disease is the initial stage of Alzheimer's where individuals may start to experience memory loss and cognitive difficulties, but can still manage daily activities.
We are investigating whether plasma from exercise-trained donors is safe and can improve cognitive function in people with early Alzheimer's disease. This study will help us understand its effects over several years.
Health conditions and diseases that the clinical trial is designed to study and treat.
Early symptomatic phase Alzheimer's disease is the initial stage of Alzheimer's where individuals may start to experience memory loss and cognitive difficulties, but can still manage daily activities.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.